Immunoadsorption, current status and future developments

Bibliography

• MINOTA S, TERAI C, NORMA Y, TAKANO K, TAKAI E, MIYAKAWA Y: Low C3b receptor reactivity on erythro-cytes from patients with systemic lupus erythema-tosus detected by immune adherence hemagglutination and radioimmunoassays with monoclonal antibody. Arthritis Rheum. (1984) 27:1329.
   PubMed Web of Science ®Google Scholar
• DAVIES KA, HIRD V, STEWART S et al: A study of in vivoimmune complex formation and clearance in man. J Immunol. (1990) 1 4 4:4613–4620.
   Google Scholar
• DAVIES KA: Complement, immune complexes andsystemic lupus erythematosus. Br. J Rheumatol. (1996) 35:5–23.
   PubMedGoogle Scholar
• CHARCOSSET C, SU Z, KAROOR S, DAUN G, COLTON CK: Protein A immunoaffinity hollow fiber membranes for immunoglobulin G purification: Experimental characterization. Biotechnol. Bioengin. (19 9 5) 48:415–427.
   Google Scholar
• SATO T, ANNO M, ARAI K, YAMAWAKI N, KURODA T, INAGAKI K: In vitro removal of anti-acetylcholine receptor antibodies with a new immunoadsorbent in sera from myasthenia gravis patients. Prog. Artif Org. (1983):719–722.
   Google Scholar
• BUCKA C et al: Immunadsorption bei Myasthenia gravis. Akt. Neurol. (1995) 20:207–213.
   Google Scholar
• SAWADA K et al.: Myasthenia gravis therapy: immuno-adsorption may eliminate need for plasma products. Cleveland Clin. J. Med. (1993) 60:60–64.
   PubMed Web of Science ®Google Scholar
• BEHM E, YAMAWAKI N, TSUDA N, KLINIKMANN H: Binding of IgE by IM-T adsorbent: in vitro studies. 1st International Congress of the World Apheresis Association. Tokyo, Japan (1986):0P-14-2. Abstract.
   Google Scholar
• YAMAZAKI Z, FUJIMORI Y, IIZOKA I et al.: Irnmunoad-sorbent plasma perfusion in patients with rheumatoid arthritis or systemic lupus erythematosus. Prog. Artif Org. (1983):708–712.
   Google Scholar
• FADUL JEM, DANIELSON BG, WIKSTROM B: Reduction of plasma fibrinogen, immunoglobulin G and immuno-globulin M concentrations by immunoadsorption therapy with tryptophan and phenylalanine adsorb-ents. Artif Organs (1996) 20:986–990.
   PubMed Web of Science ®Google Scholar
• YAMAZAKI Z: Extracorporeal immunoadsorption. 1st International Congress of the World Apheresis Association. Tokyo, Japan (1986):WS-2. Abstract.
   Google Scholar
• YUKI N: Tryptophan-immobilized column adsorbs immunoglobulin G anti-GQ1b antibody from Fisher's syndrome: A new approach to treatment. Neurology (1996) 46: 1644-1651.
   Google Scholar
• SCHMITZ-LINNEWEBER B, GAUBITZ M, SCHNEIDER M,DOMSCHKE W: Immunoadsorption in patients with SLE: In vitro investigations. Jap. J. Apher. (1996) 15 (Suppl.):S62-S62. Abstract.
   Google Scholar
• YOKOYAMA S, HAYASHI R, SATANI M, YAMAMOTO A: Selective removal of low-density-lipoprotein (LDL) by plasmapheresis in familial hypercholesterinemia. Atherosclerosis (1985) 5:613–622.
   Google Scholar
• SUZUKI N, OTUKA I, HARADA T, MIZUSHIMA Y, SAKANET: Preferential adsorption of cationic anti-DNA antibodies with immobilized polyanionic compounds, dextran sulfate. Autoimmunity (1994) 19:105–112.
   PubMed Web of Science ®Google Scholar
• MATSUKI Y, SUZUKI K, KAWAKAMI M, ISHIZUKA T, HIDAKA T, NAKAMURA H: Removal of anaphylatoxins from the plasma of systemic lupus erythematosus patients by adsorption using dextran sulfate cellulose columns. Jpn. j Apheresis (1997) 16:191–191.
   Google Scholar
• AOTSUKA S, FUNAHASHI T, TANI N, OKAWA-TAKATSUJI M, KINOSHITA M, YOKOHARI R: Adsorption of anti-dsDNA antibodies by immobilized polyanionic compounds. Clin. Exp. Immunol (1990) 79:215–220.
   PubMed Web of Science ®Google Scholar
• KUTSUKI H, TAKATA S, YAMAMOTO K, TANI N: Therapeutic selective adsorption of anti-DNA antibody using dextran sulfate cellulose column (Selesorb) for the treatment of systemic lupus erythematosus. Ther. Apher. (1998) 2:18–24.
   PubMedGoogle Scholar
• TSUDA Y, TANIGUCHI O, MOKUNO C et al.: Trial adsorp-tion of anti-cardiolipin and its application. Jpn. J Artif Org. (1989) 18:7–10.
   Google Scholar
• OGAWA H, ONO M, HISANAGA S et al: A case of severeanti-phospholipid antibody syndrome treated by immunoadsorption therapy. Proceedings of the 14th Annual Meeting of the Japanese Society for Apheresis. (1994):64–64. Abstract.
   Google Scholar
• JENSEN A: Acta Pathol. Microbic)]. Scand. A. (1958) 44:421.
   Google Scholar
• SKVARIL F: The question of specificity in binding human IgG subclasses to protein A-sepharose. Immunochemistty (1976) 13:871–872.
   PubMedGoogle Scholar
• ENDRESEN C: The binding of protein A of immuno-globulin G and of Fab and Fc fragments. Acta Pathol Microbiol. Scand. C. (1979) 87C:185–189.
   PubMedGoogle Scholar
• INGANAS M, JOHANSSON SG, SJOQUIST J: Furthercharacterization of the alternative protein-A interac-tion of immunoglobulins: demonstration of an Fc-binding fragment of protein A expressing the alternative reactivity. Scand. J. Immunol (1981) 14:379–388.
   PubMed Web of Science ®Google Scholar
• INGANAS M, JOHANSSON SG: Influence of the alterna-tive protein A interaction on the precipitation between human monoclonal immunoglobulins and protein A from Staphylococcus aureus. Int. Arch. Allergy Appl. Immunol (1981) 65:91–101.
   PubMedGoogle Scholar
• INGANAS M: Comparison of mechanisms of interac-tion between protein A from Staphylococcus aureus and human monoclonal IgG, IgA and IgMin relation to the classical Fc and alternative F(ab')2 protein A interactions. Scand. Immunol. (1981) 13:343.
   PubMed Web of Science ®Google Scholar
• INGANAS M, JOHANSSON MSGO, BENNINCH HH: Interaction of human polyclonal IgE and IgG from different species with protein A from Staphylococcus aureus: demonstration of protein A-reactive sites located in the F(aW)2 fragments of human IgG. Scand. Immunol. (1980) 12:23.
   PubMed Web of Science ®Google Scholar
• SASSO EH, SILVERMAN GJ, MANNIK M: Human IgM molecules that bind staphylococcal protein A contain VH1II H chains. J Immunol. (1989) 142:2778–2783.
   PubMed Web of Science ®Google Scholar
• LANGONE JJ: Protein A of Staphylococcus aureus andrelated immunoglobulin receptors produced by Streptococci and Pneumococci. Adv. Immunol. (1982) 32:157–252.
   PubMed Web of Science ®Google Scholar
• KESSLER SW: Rapid isolation of antigens from cellswith a staphylococcal protein A-antibody adsorbent: Parameters of the interaction of antibody-antigen complexes with protein A. J. 1171171111701. (1975) 115: 1617-1624.
   Google Scholar
• SAMTLEBEN W, SCHMIDT B, GURLAND HJ: Ex vivo andin vivoProtein A perfusion: background, basic investi-gations and first clinical experiences. Blood Purif (1987) 5:179–192.
   PubMedGoogle Scholar
• SATO H, YAMAGATA Y, KIDAKA T: Studies on quantita-tive levels of complement activation induced by immobilized and soluble forms of protein A: Relevance to extracorporeal immunoadsorption. Transfus. Sci. (1991) 12:299–305.
   Google Scholar
• RAMAN S, SNYDER H, SAWDYK M: Hemostatic altera-tions associated with extracorporeal immunoadsorp-tion using Prosorba column in the treatment of patients with immune thrombocytopenic purpura (ITP). JASN (1994) 49: (Abstract).
   Google Scholar
• SAMUELLSON G: Extracorporeal immunoadsorption with Irnmunosorba protein A. Ther. Plasmapher. (1993) 12:843–845.
   Google Scholar
• KISELEVA EA, AFANASIEVA OI, KOSHELEVA NA, POKROVSKY SN: Immunosorbent for IgG apheresis: Synthesis and characteristics. Jap. j Apher. 1996 15 (Suppl.):S50-S50. Abstract.
   Google Scholar
• LEVENTHAL JP, JOHN R, FRYER JP et al.: Removal of baboon and human antiporcine IgG and IgM natural anby immunoadsorption. Transplantation(1995) 59:294–300.
   PubMed Web of Science ®Google Scholar
• MeLLER-DERLICH J, DUMOULIN A, SPAETHE R: Extracor-poreal elimination of human immunoglobulin with IgG-Therasorb. Immunobiology (1993) 189:237-237. Abstract.
   Google Scholar
• MeLLER-DERLICH J, DUMOULIN A, SPAETHE R: Specific removal of human immunoglobulin with IgG-Ther asor b. Artif Organs (1993) 17:546-546. Abstract.
   Google Scholar
• DUMOULIN A, MeLLER-DERLICH J, BIEBER F et al.: Antibody-based immunoadsorption as a therapeutic means. Blood Purif (1993) 11:145–149.
   PubMed Web of Science ®Google Scholar
• SCHOBLER W, HIEPE F, COUPEK J, APOSTOLOFF E: Binding of C1q and DNA to support materials by means of a new coupling procedure. Biomater. Artif Cells Artif Organs (1990) 18:657–663.
   PubMedGoogle Scholar
• KNOBEL HR, VILLINGER W, ISLINKER H: Chemicalanalysis and electron microscopy studies of human C1q prepared by different methods. Eur. J Immunol. (1975) 5:78–81.
   PubMed Web of Science ®Google Scholar
• REID KBM: Isolation, by partial pepsin digestion, of thethree collagen-like regions present in subcomponent C1q of the first component of human complement. Biochem. J. (1976) 155:5–17.
   PubMed Web of Science ®Google Scholar
• DUNCAN AR, WINTER G: The binding site for C1q on IgG. Nature (1988) 332:738–740.
   PubMed Web of Science ®Google Scholar
• HIEPE F, PFeLLER B, WOBART K et al.: C1 q: A multifunc-tional ligand for a new immunoadsorption treatment. Ther. Apher. (1999) 3:246–251.
   PubMedGoogle Scholar
• LARSSON A, FREIBURGHAUS C, NILSSON IM, SUNDQVISTSB, BYGREN P, LINDHOLM T: Plasma regeneration system for extensive immunoadsorption. Prog. Artif Org. (1985)902–904.
   Google Scholar
• KELLER F, WAGNER K, FABER U et al.: Eliminationkinetics of plasma exchange. Kiln. Wochenschr. (1983) 61:1115–1122.
   PubMedGoogle Scholar
• DAVIES PA: Model of removal of immunoglobulinsfrom plasma by extracorporeal immunoadsorption with sepharose-protein A. Int. J Artif Organs (1990) 13:837–845.
   PubMed Web of Science ®Google Scholar
• WANIEWSKI J, PRIKRYLOVA D: A mathematical modelof extracorporeal antibody removal in autoimmune disease. Int. j Artif Organs (1989) 12:471–476.
   PubMed Web of Science ®Google Scholar
• EULER HH, SCHROEDER JO, SCHWAB UM, ZEUNER RA, MOLLER J, FASTENRATH S: International trial on the treatment of severe systemic lupus erythematosus with synchronized plasmaphereses and pulse-cyclophosphamide `LPSG-Trial' (Final Report). 3-1-99. (Internet Communication)
   Google Scholar
• BRAUN N, RISLER T: Irnmunoadsorption as a tool for the immunomodulation of the humoral and cellular immune system in autoimmune disease. Ther. Apher. (1999) 3:240–245.
   PubMedGoogle Scholar
• BRAUN N, FAUL C, WERNET D et al.: Successfultransplantation of highly selected CD34+ peripheral blood stem cells in a HLA-sensitised patient treated with immunoadsorption onto protein A. Transplanta-tion (2000) 69: 1742-1744.
   Google Scholar
• BEVAN DJ, CAREY BS, VAUGHAN RW et al.: Modulationof anti-HLA antibody production following renal transplantation in sensitised, immunoadsorbed patients. Transplant. Proc. (1997) 29:1448.
   PubMed Web of Science ®Google Scholar
• BEVAN DJ, CAREY BS, LEA CK et al.: Antibody removaland subsequent transplantation of a highly sensitised paediatric renal patient. Transpl. Int. (1996) 9:155–160.
   PubMed Web of Science ®Google Scholar
• NILSSON IM, JONSSON S, SUNDQVIST SB, AHLBERG A,BERGENTZ SE: A procedure for removing high titer antibodies by extracorporeal protein-A sepharose adsorption in hemophilia: Substitution therapy and surgery in a patient with hemophilia B and antibodies. Blood (1981) 58:38–44.
   PubMed Web of Science ®Google Scholar
• FREIBURGHAUS C, BERNTORP E, EKMAN M, GUNNARSSON M, KJELLBERG BM, NILSSON IM: Immuno-adsorption for removal of inhibitors: update on treatments in Malmo-Lund between 1980 and 1995. Haemophilia (1998) 4:16–20.
   PubMed Web of Science ®Google Scholar
• GJORSTRUP P, BERNTORP E, LARSSON L, NILSSON IM: Kinetic aspects of the removal of IgG and inhibitors in hemophiliacs using protein A immunoadsorption. Vox Sang. (1991) 61:244–250.
   PubMed Web of Science ®Google Scholar
• GROBMANN R, WANKMOLLER H, SCHVVENDER S et al: Diagnose und Therapie eines erworbenen Faktor-VIII-Inhibitors in Kombination mit Lupus-Antikoagulanzien. Dutsch Med. Wochenschr. (1996) 121:906–910.
   PubMedGoogle Scholar
• KNOBL P, DERFLER K, KORNINGER L et al.: Elimination of acquired Factor VIII antibodies by extracorporeal antibody-based immunoadsorption (Ig-Therasorb). Thrombosis Haemostasis (1995) 74:1035–1038.
   PubMed Web of Science ®Google Scholar
• TRIBL B, KNOBL P, DERFLER K et al: Rapid elimination of a high-titer spontaneous Factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression. Ann. Hematol. (1995) 71:199–203.
   PubMed Web of Science ®Google Scholar
• KIZAKI M, IKEDA Y: Red cell fragmentation and hemolysis in thrombotic thrombocytopenic purpura (TTP). Nippon. Rinsho. (1993) 51:117–121.
   PubMedGoogle Scholar
• SNYDER HVV, JR., MITTELMAN A, ORAL A et al.: Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein Aimmunoadsorption of plasma. Cancer (1993) 71:1882–1892.
   Google Scholar
• JULIUS U, PATZAK A, SCHAICH M, EHNINGER G, KAMIN G: Immunogene Thrombozytopenie, Animie und lzukopenie während der Schwangerschaft. Deutsch Med Wochenschr. (1997) 122:220–224.
   PubMedGoogle Scholar
• SNYDER HW, JR., SEAWELL BW, COCHRAN SK, BALINT JP, JR., JONES FR: Specificity of antibody responses affected by extracorporeal immunoadsorption of plasma over columns of protein A silica. J. Clin. Apheresis. (1992) 7:110–118.
   PubMedGoogle Scholar
• BALINT JP, JR.: Immune modulation associated with extracorporeal immunoadsorption treatments utilizing protein A/silica columns. Anil: Organs (1996) 20:906–913.
   PubMed Web of Science ®Google Scholar
• BALINT JP, JR., HUSSEIN MA, QUAGLIATA F, COCHRAN S, JONES FR: Modulation of idiotypic and antiidiotypic immunoglobulin G responses in an alloimmune thrombocytopenic patient associated with extracor-poreal protein A immunoadsorption. Anil: Organs (1996) 20:266–270.
   PubMed Web of Science ®Google Scholar
• CAHILL MR, MACEY MG, CAVENAGH JD, NEWLAND AC: Protein A immunoadsorption in chronic refractory ITP reverses increased platelet activation but fails to achieve sustained clinical benefit. Br. J Haemtol (1998) 100:358–364.
   PubMed Web of Science ®Google Scholar
• GUTHRIE TH, JR., ORAL A: Immune thrombocytopenia purpura: A pilot study of Staphylococcal Protein A immunomodulation in refractory patients. Semin. Hematol. (1989) 26 (Suppl. 1):3–9.
   Google Scholar
• MUROI K, SASAKI R, MIURA Y: The effect of immunoad-sorption therapy by a protein A column on patients with thrombocytopenia. Semin. Hematol. (1989) 26 (Suppl. 1) :10–14.
   Google Scholar
• REMUZZI G, MISIANI R, MARCHESI D et al.: Treatment ofthe hemolytic uremic syndrome with plasma. Clin. Nephrol. (1979) 12:279–284.
   PubMed Web of Science ®Google Scholar
• KWAAN HC, SOFF GA: Management of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin. Hematol. (1997) 34:159–166.
   PubMed Web of Science ®Google Scholar
• D'SOUZA RJ, KWAN JT, HENDRY BM, FALLON M, CUNNINGHAM D: Successful outcome of treating hemolytic uremic syndrome associated with cancer chemotherapy with immunoadsorption. Clin. Nephrol (1997) 47:58–59.
   PubMed Web of Science ®Google Scholar
• DUA A, ZEIGLER ZR, SHADDUCK RK, NATH R, ANDREWS DF, AGHA M: Apheresis in grade 4 bone marrow transplant associated thrombotic microangiopathy: a case series. J Clin. Apheresis (1996) 11:176–184.
   PubMed Web of Science ®Google Scholar
• LEWIS EJ, HUNSICKER LG, LAN SP, ROHDE RD, LACHIN JM: A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collabo-rative Study Group [see comments]. N Engl. J. Med. (1992) 326:1373–1379.
   Google Scholar
• BRAUN N, ERLEY C, KLEIN R, KOTTER I, SAAL J, RISLER T: Immunoadsorption onto protein A induces remission in life-threatening systemic lupus erythematosus. Nephrol. Dial. Transplant. (2000) (In Press).
   Google Scholar
• FUNAUCHI M, OHNO M, YAMAZOE Y et al.: Three casesof systemic lupus erythematosus treated by immuno-adsorbent plasma perfusion with a dextran-sulfate column. In: Therapeutic apheresis (X): Eleventh symposium, Tokyo, Japan, September 27–28, 1991. (321 edition).Yamagata J, Inoue N, Nakagawa S, (Eds.), ICAOT Press Publication, Cleveland, Ohio, USA (1992):214–218.
   Google Scholar
• SUZUKI K, HARA M, HARIGAI M et al.: Continuousremoval of anti-DNA antibody, using a new extracor-poreal immunoadsorption system, in patients with systemic lupus erythematosus. Arthritis Rheum. (1991) 34:1546–1552.
   PubMed Web of Science ®Google Scholar
• RICHTER KC: Prosorba Column. Application letter to FDA(1999).
   Google Scholar
• FELSON DT, LAVALLEY MP, BALDASSARE AR et al.: TheProsorba column for treatment of refractory rheuma-toid arthritis. Arthritis Rheum. (1999) 42:2153–2159.
   PubMed Web of Science ®Google Scholar
• TSURUTA Y, MAEDA K, SHINZATO T et al.: Treatment of SLE and RA with new immunoadsorbent. In: Therapeutic plasmapheresis Hi (3rd Edition). Oda T (Ed.), Schattauer Verlag, Stuttgart, Germany (1983):241–245.
   Google Scholar
• GLOCKNER WM, SIEBERTH HG, WICHMANN HE et al.: Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study. Clin. Nephrol (1988) 29:1–8.
   PubMed Web of Science ®Google Scholar
• PUSEY CD, REES AJ, EVANS DJ, PETERS DK, LOCKWOOD CM: Plasma exchange in focal necrotizing glomeru-lonephritis without anti-GBM antibodies. Kidney Int. (1991) 40:757–763.
   PubMed Web of Science ®Google Scholar
• RISLER T, BRAUN N, BACH D et al.: The GermanGlomerulonephritis Therapy Study: 10 years of controlled randomized trials for the treatment of idiopathic glomerulonephritis. Kidney Blood Press. Res. (1996) 19:196–200.
   PubMed Web of Science ®Google Scholar
• PETERS DK, REES AJ, LOCKWOOD CM, PUSEY CD: Treatment and prognosis in antibasement membrane antibody- mediated nephritis. Transplant. Proc. (1982) 1 4:513–521.
   Google Scholar
• BYGREN P, FREIBURGHAUS C, LINDHOLM T, SIMONSEN O, THYSELL H, WIESLANDER J: Goodpasture's syndrome treated with staphylococcal protein A immunoadsorption [letter]. Lancet (1985) 2:1295–1296.
   PubMed Web of Science ®Google Scholar
• MOGK M, WELCKER M, HELMKE K. KASUISTIK: Therapie der Anti-basalmembranglomerulonephritis mittels Immunadsorption. Immun. Infekt. (1995) 23:187–189.
   Google Scholar
• SCHINDLER R, KAHL A, LOBECK H, BERWECK S, KAMPF D, FREI U: Complete recovery of renal function in a dialysis-dependent patient with Goodpasture syndrome. Nephrol. Dial. Transplant. (1998) 13:462–466.
   PubMed Web of Science ®Google Scholar
• ESNAULT VL, TESTA A, JAYNE DR, SOULILLOU JP, GUENEL J: Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonephritis. Nephron (1993) 65:180–184.
   PubMedGoogle Scholar
• MORESO F, POVEDA R, GIL VERNET S et al.: Inmunoad-sorcion terapeutica en la enfermedad de Goodpasture. Med. Clin. Barc. (1995) 10:59–61.
   Google Scholar
• STEGMAYR BG, ALMROTH G, BERLIN G et al.: Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis - A Swedish multi-center study. Int. j Artif Organs (1999) 22:81–87.
   PubMed Web of Science ®Google Scholar
• BACH D, HAUSER K, HELMCHEN U, GRABENSEE B: Klinischer Verlauf der rapid-progredienten Glomeru-lonephritis - eine Untersuchung an 50 konsekutiven Patienten. Nieren Hochdruckkrankh. (1995) 24:442-442. Abstract.
   Google Scholar
• ZAUNER I, BOHLER J, BACH D et al.: Therapie undPrognose der rapid progressiven Glomerulonephritis. Ergebnisse der deutschen prospektiven Multicenter-studie. Nieren Hochdruckkrankh. (1995) 24:442-442. Abstract.
   Google Scholar
• KJELLBERG BM, SEGELMARK M, FREIBURGHAUS C: A comparative study between plasma exchange and immunoadsorption on the removal of ANCA. 2nd International Congress of the International Society for Apheresis (1999):104–104. Abstract.
   Google Scholar
• SEGELMARK M, KJELLBERG BM, HARDLUND J, FREIBURGHAUS C: A comparative study between plasma exchange and immunoadsorption on removal of ANCA. (1995): (Poster presentation, ASN).
   Google Scholar
• PALMER A, CAIRNS T, DISCHE F et al.: Treatment ofrapidly progressive glomerulonephritis by extracor-poreal immunoadsorption, prednisolone and cyclophosphamide. Nephrol. Dial. Transplant. (1991) 6:536–542.
   PubMed Web of Science ®Google Scholar
• JACQUOT C, RADEAU E, NOCHY D, BARIETY J, DRUET P:Nephrotic syndrome, linear glomerular IgG deposits and minimal glomerular changes. Report of a case. Arch. Intern. Med. (1981) 141 :670–672.
   PubMedGoogle Scholar
• RISLER T, BRAUN N, ERLEY CM: Therapie der primirenGlom erulonep hritiden. Arzneimitteltherapie (2000) 1 7 :403–409.
   Google Scholar
• SAVIN VJ, SHARMA R, SHARMA M et al: Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomeruloscle-rosis. N Engl. J. Med. (1996) 3 3 4:878–883.
   Google Scholar
• GINSBURG DS, DAU P: Plasm ap h er esis in the treatment of steroid-resistant focal segmental glomeruloscle-rosis. Clin. Nephrol. (1997) 48:282–287.
   PubMed Web of Science ®Google Scholar
• HAAS M, OBERBAUER R, BORCHHARDT K, DRUML W, MAYER G: Variable effects of plasma protein adsorp-tion on glomerular permselectivity in primary focal and segmental glomerulosclerosis. J. Am. Soc. Nephrol (1995) 6:1014-1014. Abstract.
   Google Scholar
• FRANKE D, ZIMMERING MT, WOLFISH N, FILLER G: Treatment of focal (and) segmental glomeruloscle-rosis with plasma exchange and immunoadsorption in children. J. Am. Soc. Nephrol (1999) 1 0:100A-101A. Abstract.
   Google Scholar
• DANTAL J, GODFRIN Y, KOLL R et al.: Antihuman immunoglobulin affinity immunoadsorpiton strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J. Am. Soc. Nephrol. (1998) 9:1709–1715.
   PubMed Web of Science ®Google Scholar
• DANTAL J, BIGOT E, BOGERS W et al.: Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl. J. Med. (1994) 330:7–14.
   PubMed Web of Science ®Google Scholar
• ROSENFELD S, BRAUN N, DINICUOLO A, GUAGNIN M, RISLER T: Kinetics of immunological, and biochemical parameters during protein-A immunoadsorption in patients with recurrent focal and segmental glomeru-losclerosis. Proceedings of the 2nd Internet Congress on Biomedical Science (CD-ROM publication). Murase S, Taniguchi Y, Mukai J, Ishikawa H, Tsudal M, Yamamura M, Takada T (Eds.), Fujitsu, Tokio, Japan (1996).
   Google Scholar
• BESNIER D, MARTIN S, CHABANNES D, TESTA A, SIMON P, ESNAULT V: Protein A immunoadsorption (IA) reduces proteinuria in patients with nephrotic syndrome and membranous nephropathy. Nephrol Dial. Transplant. (1995). Abstract.
   Google Scholar
• ALARABI AA, WIKSTROM B, BACKMAN U, DANIELSON BG, TUFVESSON G, SJOBERG O: Pretransplantation immunoadsorption therapy in patients immunized with human lymphocyte antigen: effect of treatment and three years' clinical follow-up of grafts. Artif Organs (1993) 1 7 :702–707 .
   Google Scholar
• GJORSTRUP P: An ti-HLA antibody removal in hyp erim-munized ESRF patients to allow transplantation. Transplant. Proc. (1991) 23:392–395.
   PubMed Web of Science ®Google Scholar
• HAKIM RM, MILFORD E, HIMMELFARB J, WINGARD R, LAZARUS JM, WATT RM: Extracorporeal removal of anti-HLA antibodies in transplant candidates. Am. J. Kidney Dis. (1990) 1 6 :423–431 .
   Google Scholar
• HIGGINS RM, BEVAN DJ, CAREY BS et al.: Prevention of hyperacute rejection by removal of antibodies to HLA immediate before renal transplantation. Lancet (1996) 348:1208–1211.
   PubMed Web of Science ®Google Scholar
• KUPIN WL, VENKAT KK, HAYASHI H, MOZES MF, OH HK, WATT R: Removal of lymphocytotoxic antibodies by pretransplant immunoadsorption therapy in highly sensitized renal transplant recipients. Transplantation (1991) 51:324–329.
   PubMed Web of Science ®Google Scholar
• OLIVARI MT, MAY CB, JOHNSON NA, RING WS, STEPHENS MK: Treatment of acute vascular rejection with immunoadsorption. Circulation (1994) 90 (part 2):11-70-II–73.
   Google Scholar
• PRETAGOSTINI R, BERLOCO P, POLI L et al: Inimun oad-sorption with protein A in humoral rejection of kidney transplants. ASAIO J. (1996) 42:M645–M648.
   PubMed Web of Science ®Google Scholar
• REISAETER AV, LEIVESTAD T, ALBRECHTSEN D et al.: Pretransplant plasma exchange or immunoadsorp-tion facilitates renal transplantation in immunized patients. Transplantation (1995) 60:242–248.
   PubMed Web of Science ®Google Scholar
• SCHAUMANN D, BRUNKHORST R, MOLLER R et al.: Kombinationsbehandlung mit IgG-Irnmunadsorption und IgG-Substitution zur Supression zytotoxischer Antikorper vor Merentransplantation (NTX). Nieren Hochdruckkrankh (1994)9.
   Google Scholar
• MASTRANGELO F, PRETAGOSTINI R, BERLOCO P et al.: Irnmunoadsorption with protein A in humoral acute rejection of kidney transplants: multicenter experi-ence. Transplant. Proc. (1995) 27:892–895.
   PubMed Web of Science ®Google Scholar
• BEVAN DJ, CAREY BS, VAUGHAN R et al: Anticipation of highly-sensitised renal patients' immunoadsorption requirements by prescreening using protein A minicolumns. Transpl. Int. (1996) 9 (Suppl. 1):S20–S24.
   Google Scholar
• PALMER A, TAUBE D, WELSH K, BEWICK M, GJORSTRUP P, THICK M: Removal of anti-MA antibodies by extracorporeal immunoadsorption to enable renal transplantation. Lancet (1989) I:10–12.
   Google Scholar
• HIGGINS RM, BEVAN DJ, VAUGHAN JH et al.: 5-year follow-up of patients successfully transplanted after immunoadsorption to remove anti-HLA antibodies. Nephron (1996) 74:53–57.
   PubMedGoogle Scholar
• PLASMA EXCHANGE/SANDOGLOBIN GUILLAIN-BARRE SYNDROME TRIAL GROUP: Randomised trial of plasma exchange, intravenous immunoglobulin and combined treatments in Guillain-Barre syndrome. Lancet (1997) 349:225–230.
   PubMed Web of Science ®Google Scholar
• VAN DER MECHE FGA, SCHMITZ PIM: Arandomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. N Engl. J. Med. (1992) 326:1123–1129.
   PubMed Web of Science ®Google Scholar
• YEH JH, CHIU HC: Optimal volume of processed plasma and total number of selective plasmapheresis sessions in the treatment of patients with severe generalized myasthenia gravis. j Clin. Apheresis (1999) 14:177–180.
   PubMed Web of Science ®Google Scholar
• KUWABARA S, NAKAJIMA M, MOROO I, HIRAYAMA K: Double filtration and immunoadsorption plasma-pheresis in Guillain-Barre syndrome. Rinsho. Shinkei-gaku. (1996) 36:289–292.
   PubMedGoogle Scholar
• ROSENOW F, HAUPT WF, GRIEB P, JIMENEZ-KLINGBERG C, BORBERG H: Plasma exchange and selective adsorp-tion in Guillain-Barre syndrome - a comparison of therapies by clinical course and side effects. Transfus. SO. (1993) 14:13–15.
   PubMedGoogle Scholar
• NIKOLAY J, BRAUN J, DRUSCHKY KF, GREILING HW, GESSLER U: Klinische Erfahrung mit der Immunad-sorption bei Myasthenia gravis und Polyradikulitis. Nieren Hochdruckkrankh (1987) 16:455–460.
   Google Scholar
• PENCZ A, GARNIER E: Immunadsorption in der Behandlung der Polyradikulitis vom Typ Guillain Barre. Nervenarzt (1990) 6 1 :372–375.
   Google Scholar
• GURLAND HJ, SAMTLEBEN W: Klinische Einsatz-möglichkeiten und technische Durchfiihrung der Plasmapherese. Internist (1983) 24:14–26.
   PubMedGoogle Scholar
• SHIBUYA N, SATO T, OSAME M, TAKEGAMI T, DOI S, KAWANAMI S: Immunoadsorption therapy for myasthenia gravis. j Neurol. Neurosurg. Psychiatry (1994) 57:578–581.
   PubMed Web of Science ®Google Scholar
• BERNING T, KRUMMENERL T, GLASER J, PAULUS H, VAN HUSEN N: Irnmunadsorption - eine neue Therapie der Myasthenia gravis. Med. Klinik (1988) 83:125–128.
   Google Scholar
• HEININGER K: In-vitro- undUn ter suchungenzur selektiven Immunadsorptionsbehandlung neurologischer Erkrankungen. Schriftenr. Neurol. (1993) 33:1–91.
   PubMedGoogle Scholar
• HEININGER K, TOYKA KV, GACZKOWSKI A, HARTUNG HP, BORBERG H, GRABENSEE B: Selective removal of pathogenic factors in neurologic disease. Plasma Ther. Transfus. Technol (1986) 7:351–357.
   Google Scholar
• TOYKA KV, BESINGER UA, HEININGER K et al.: Myasthenia gravis: the pathogenic of antibodies to acetylcholine receptor and the effect of antibody depletion. In: Plasma exchange therapy. International Symposium Wiesbaden 1980. (1 st Edition). Borberg H, Reuther P (Eds.), Thieme, Stuttgart, Germany (1980171–171.
   Google Scholar
• MESSERSCHMIDT GL, HENRY DH, SNYDER-HW J et al.: Protein A immunotherapy in the treatment of cancer: an update. Semin. Hematol. (1989) 26 (Suppl. 0:19–24.
   Google Scholar
• LIMAS CJ: Cardiac autoantibodies in dilated cardiomyo-pathy. A pathogenic role? Circulation (1997) 95:1979–1980.
   PubMed Web of Science ®Google Scholar
• DORFFEL WV, FELIX SB, WALLUKAT G et al.: Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation (1997) 95:1994–1997.
   PubMed Web of Science ®Google Scholar
• MULLER J, WALLUKAT G, DANDEL M et al.: Irnmuno-globulin adsorption in patients with idiopathic dilated car diomyop athy. Circulation (2000) 101:385–391.
   PubMed Web of Science ®Google Scholar
• NILSSON IM, FREIBURGHAUS C: Apheresis. In: Inhibitors to coagulation factors. Aledort LM, (Ed.), Plenum Press, New York, USA (1995):175–184.
   Google Scholar
• CARRUTHERS SG, LAROCHELLE P, HAYNES RB, PETRASO-VITIS A, SCHIFFERIN EL: Report of the Canadian Hypertension Society Consensus Conference. I. Introduction. Can. Med. Assoc. J. (1993) 149:289–292.
   PubMed Web of Science ®Google Scholar